|
Status |
Public on Feb 13, 2018 |
Title |
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
28967519 |
|
Submission date |
Jun 13, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Michael Katze |
E-mail(s) |
data@viromics.washington.edu
|
Organization name |
University of Washington
|
Department |
Microbiology
|
Lab |
Michael G. Katze, Ph.D
|
Street address |
Rosen Building 960 Republican St.
|
City |
Seattle |
State/province |
WA |
ZIP/Postal code |
98109-4325 |
Country |
USA |
|
|
Platforms (2) |
GPL17077 |
Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381 (Probe Name version) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (124)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE81951 |
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] |
GSE83215 |
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [Microarray Expression] |
|
Relations |
BioProject |
PRJNA325484 |